Filter
135
Featured
Recommendations
23
New Publications
34
Language
Document type
Guidelines
72
Studies & Reports
21
Manuals
13
Resource Platforms
7
Training Material
6
Fact sheets
6
Online Courses
4
Strategic & Response Plan
3
No document type
2
Videos
1
Countries / Regions
Ghana
4
South Africa
4
Latin America and the Carribbean
4
Kenya
3
Malawi
3
Global
3
Liberia
2
Ethiopia
2
India
2
Tanzania
2
Rwanda
2
Western and Central Europe
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Nigeria
1
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Uganda
1
Zimbabwe
1
Philippines
1
Somalia
1
China
1
Sudan
1
Central African Republic
1
Argentina
1
Ukraine
1
Eastern Europe and Central Asia
1
Africa
1
Fiji
1
Russia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
30
Pharmacy & Technologies
16
Key Resources
11
Clinical Guidelines
5
Women & Child Health
4
Capacity Building
3
Public Health
2
Annual procurement workplan for ordering medicines.
Last revised 2015.
Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Workplan_Form.doc
Last revised 2015.
Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Cleaning_SOP.doc
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
The 6th edition of the essential medicine list has been developed based on the 5th edition list of essential medicines, the National Standard Treatment Guidelines and Protocols 2013, list of laboratory commodities and List of Consumables used in public health facilities.
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
Information and Approaches for developing Country Settings
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuadorian Ministry of Health to implement its Child Survi
...
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
Acupuncture has been practised for more than 2500 years in the Western Pacific Region and has become a global therapeutic method in recent decades. However, it was reportedthat acupuncturists differed by up to 25% in the acupuncture points they used, raising doubts and uncertainty regarding the effi
...
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...